Brendan Smith

Brendan joined Translate Bio as Chief Financial Officer & Corporate Strategy in 2021. Brendan is responsible for Translate Bio’s finance and accounting, information technology, investor relations, and corporate strategy functions while working with the Company’s leadership team to ensure measured growth while executing on its strategic plan. Previously, as a Partner at Boston Consulting Group, Brendan led integrated biopharma client engagements that included planning and executing on R&D strategy, operations, business development and deal diligence. Prior to that, Brendan was VP, Head of Business Operations for Worldwide R&D at Pfizer where he led financial and headcount planning across discovery and development operations. In addition, as Executive Director, Head of Business Strategy and Operations for Biologics Pharmaceutical Sciences at Pfizer, Brendan led manufacturing and financial operations for the company’s global biologics process development organization. Brendan received a B.S. in Biochemistry from Worcester Polytechnic Institute and an M.B.A. from Harvard Business School.